The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Pyrogen Testing Global Market Report 2024, the pyrogen testing market is expected to show significant growth in the forecast period.

1. Introduction

The pyrogen testing market has witnessed rapid growth, emerging as a critical player in ensuring the safety of pharmaceutical and biotechnological products. In 2023, the market size reached $1.46 billion, projected to soar to $1.67 billion in 2024, boasting a Compound Annual Growth Rate (CAGR) of 14.2%. Looking ahead, the forecast is equally promising, with an anticipated growth to $2.72 billion in 2028, marking a CAGR of 13.0%. This robust growth can be attributed to various factors, including the rise in infectious diseases, advancements in testing methods, and increased adoption in medical device manufacturing.

2. Infectious Diseases Driving Market Demand
3. Pyrogen Testing Crucial for Safety

• Pyrogen testing plays a pivotal role in detecting fever-causing contaminants in drugs and medical devices.
• Essential step to ensure the safety of pharmaceutical products.

1. Rise in Infectious Diseases

• According to the Centers for Disease Control and Prevention, there has been an increase in central line-associated bloodstream infection (CLABSI) and catheter-associated urinary tract infection (CAUTI) between 2020 and 2021.
• Global increase in infectious diseases propels the growth of the pyrogen testing market.

3. Major Companies in the Pyrogen Testing Market

• Key Players:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Charles River Laboratories Inc.
  • Lonza Group Ltd.
  • Associates of Cape Cod Inc.
  • GenScript Biotech Corporation
  • Eurofins Scientific SE
  • SGS SA
  • Bio-Rad Laboratories Inc.
  • STERIS Corporation

View More On The Pyrogen Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

4. Animal-Free Pyrogen Testing Innovations
5. Evolution of Animal-Free Methods

• Companies focus on animal-free pyrogen testing methods, such as the monocyte activation assay (MAT).
• Overcoming constraints of traditional rabbit pyrogen testing and Limulus Amebocyte Lysate (LAL) test.

1. Merck’s PyroDetect and PyroMAT Systems

• Merck introduces two MAT systems, PyroDetect and PyroMAT, for the detection of both endotoxin and non-endotoxin pyrogens.
• These systems aim to provide a human treatment of animals and offer better predictability of pyrogenic activity.

5. Market Segmentation and Regional Insights

• Segmentation:
  1. By Test Type: LAL Test, In Vitro Test, Rabbit Test
  2. By Product And Service: Assays, Kits, And Reagents, Instruments, Services
  3. By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications
• Regional Insights:

• • North America dominated the pyrogen testing market in 2023.
  • Asia-Pacific is projected to be the fastest-growing region during the forecast period.

6. Conclusion

As the pyrogen testing market continues to flourish, driven by the imperative need for product safety in pharmaceutical and biotechnological industries, it stands at the forefront of ensuring health and well-being. The ongoing innovations in animal-free testing methods and the relentless focus on addressing infectious diseases emphasize the industry’s commitment to advancing healthcare safety standards. Stakeholders in the pyrogen testing market are poised to play a pivotal role in the dynamic landscape of health protection, fostering transparency, traceability, and personalized solutions in the testing processes.

Request A Sample Of The Global Pyrogen Testing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=4020&type=smp